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Adverse outcome pathway 
A B S T R A C T   
HepG2 and THP-1 cells, the latter differentiated by phorbol 12-myristate 13-acetate (PMA), were co-cultured 
and characterized for typical liver-specific functions, such as xenobiotic detoxification, lipid and cholesterol 
metabolism. Furthermore, liver injury-associated pathways, such as inflammation, were studied. In general, the 
co-cultivation of these cells produced a pro-inflammatory system, as indicated by increased levels of cytokines 
(IL-8, TGF-α, IL-6, GM-CSF, G-CSF, TGF-β, and hFGF) in the respective supernatant. Increased expression levels 
of target genes of the aryl hydrocarbon receptor (AHR), e.g., CYP1A1, CYP1A2 and CYP1B1, were detected, 
accompanied by the increased enzyme activity of CYP1A1. Moreover, transcriptome analyses indicated a sig-
nificant upregulation of cholesterol biosynthesis, which could be reduced to baseline levels by lovastatin. In 
contrast, total de novo lipid synthesis was reduced in co-cultured HepG2 cells. Key events of the adverse outcome 
pathway (AOP) for fibrosis were activated by the co-cultivation, however, no increase in the concentration of 
extracellular collagen was detected. This indicates, that AOP should be used with care. In summary, the indirect 
co-culture of HepG2/THP-1 cells results in an increased release of pro-inflammatory cytokines, an activation of 
the AHR pathway and an increased enzymatic CYP1A activity.   
1. Introduction 
The liver is the main organ of intermediary metabolism. When taken 
up orally, nutrients, noxious and/or pharmacologically active com-
pounds reach the liver through the portal vein. Consequently, appro-
priate in vitro liver models are widely discussed and developed for 
toxicological and pharmacological studies (Zeilinger et al., 2016;  
Soldatow et al., 2013; Toyoda et al., 2017; Zhou et al., 2019). Primary 
human liver cells are thus far the “gold standard” for these in vitro in-
vestigations (Zeilinger et al., 2016; Soldatow et al., 2013). However, 
one should be aware of the short comings of this “gold standard”, for 
instance, large inter-individual differences, reduction in functionality 
within days (Soldatow et al., 2013) and induction of signalling path-
ways and changes in enzyme activity due to disease-related patient 
treatment. On the other hand, hepatic cell lines (e.g., HepG2, Huh7) 
also have limitations, since the metabolic enzyme activity of these cells 
is often much lower or absent than that of primary cell cultures (Hewitt 
and Hewitt, 2004; Lin et al., 2012). However, availability is almost 
unlimited, since these cells can be easily expanded in the laboratory. 
Differences between primary human hepatocytes and HepG2 cells in 
the response to pharmacologically active substances were investigated 
recently (Albrecht et al., 2019). Primary hepatocytes were more sui-
table for the detection of toxic effects, compared to HepG2 cells. In 
addition, it was shown that the read out was of crucial importance. The 
authors concluded that HepG2 cells represent a suitable screening tool 
to study most of these substances (Albrecht et al., 2019). Besides the 
single cultivation of HepG2 cells, co-culturing of HepG2 cells (e.g. with 
THP-1 cells) could also lead to more sensitive cell culture model. 
However, much more complex 3D co-cultures have generated pro-
mising pro-fibrotic hepatic in vitro systems (Prestigiacomo et al., 2017). 
In this system, essential interactions between hepatocytes, Kupffer cells 
and stellate cells (by HepaRG, THP-1, hTERT-HSC) were successfully 
simulated in vitro. This study showed that co-cultivation systems could 
have a higher validity compared to single cultures and that THP-1 cells 
can be a possible surrogate for human Kupffer cells. (Prestigiacomo 
et al., 2017).THP-1 cells, differentiated by phorbol 12-myristate 13- 
acetate (PMA), convert into a macrophage-like phenotype (Schwende 
et al., 1996). Wewering and co-workers (Wewering et al., 2017a) 
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established an indirect co-cultivation system with HepG2 and PMA- 
differentiated THP-1 cells. This co-cultivation resulted in a pro-in-
flammatory system, as indicated by the secretion of C–X–C-motif ligand 
8 (CXCL8 or IL-8), granulocyte macrophage colony-stimulating factor 
(GM-CSF) and macrophage migration inhibitory factor. Granitzny and 
co-workers (Granitzny et al., 2017) investigated the suitability of this 
co-cultivation system for the identification of drugs that induce liver 
injury (DILI). Positive reference substances for DILI like troglitazone, 
trovafloxacin, diclofenac and ketoconazole as well as negative reference 
substances like rosiglitazone, levofloxacin, acetylsalicylic acid, fluco-
nazole were correctly identified and proved the functionality of the 
system. In addition, tumour necrosis factor α (TNF-α) was identified as 
a prognostic factor for DILI development in vitro (Granitzny et al., 
2017). These findings support the hypothesis that pro-inflammatory 
conditions might lower the hepatotoxic thresholds of xenobiotics or 
drugs and can lead to DILI (Roth et al., 2003). 
The main focus of the present paper are changes at the cellular level 
that were induced by the indirect co-cultivation of HepG2 and PMA- 
differentiated THP-1 cells. Therefore, gene expression profiles were 
determined by transcriptome analyses. The predictions were then va-
lidated by measuring cytokine secretion, CYP enzyme expression and 
specific enzyme activities, collagen accumulation and changes in the 
amount of total lipids. Finally, crucial hepatic pathways that were 
changed due to the co-cultivation conditions were identified, which 
allows a deeper understanding of the co-cultivation system. 
2. Methods 
All methods were carried out according to the manufacturer's pro-
tocol. Only the modifications are given below. 
2.1. Chemicals and antibodies 
All chemicals were purchased from Sigma-Aldrich (Taufkirchen, 
Germany) unless stated otherwise. In general, Dulbecco's phosphate- 
buffered saline (DPBS, PAN-Biotech, Aidenbach, Germany) was used. A 
list of the antibodies used is provided in supplementary table S1. 
2.2. Cell culture 
All single use consumables were purchased from TPP (Trasadingen, 
Switzerland). Cell lines were purchased from DSMZ (Braunschweig, 
Germany). HepG2 cells were grown in RPMI 1640 (PAN-Biotech, 
Aidenbach, Germany) contained 10% (v/v) FCS, 100 U/ml penicillin, 
100 mg/ml streptomycin, 2 mM L-glutamine at 37 °C and 5% CO2 as 
described previously. THP-1 cells were grown in RPMI 1640 (PAN- 
Biotech, Aidenbach, Germany) contained 10% (v/v) FCS, 100 U/ml 
penicillin, 100 mg/ml streptomycin, 2 mM L-glutamine, 1 mM sodium 
pyruvate, 10 mM Hepes and the co-culture were performed using 
Falcon® cell culture inserts (VWR, Darmstadt, Germany) according to 
Wewering and co-workers (Wewering et al., 2017a). HepG2 cells were 
seeded at a density of 1.3 × 105 cells per cm2. THP-1 cells were seeded 
at a density of 0.65 × 105 cells per cm2 and differentiated using 100 nM 
phorbol-12-myristat-13-acetat (PMA) for 24 h. Immediately after dif-
ferentiation the co-cultivation with the HepG2 cells was started. Pre-
viously it has been shown that PMA in the concentration range of 
8–200 nM can be used for a successful differentiation and adherence of 
the cells to the culture vessel within 24 h (Lund et al., 2016). However, 
during a subsequent PMA free cultivation phase the adherence de-
creased with a decreasing PMA concentration. THP-1 cells, that were 
differentiated with 100 nM PMA showed the highest adherence 24 h 
after cultivation in the absence of PMA. Secondly, the concentration of 
PMA as well as incubation and resting phase seems to affect the toxicity 
of drugs. Granitzny and co-workers (Granitzny et al., 2017) studied the 
effect of ketoconazole on THP-1 cells, differentiated for 72 h in the 
presence of 50 nM PMA, followed by a resting phase in PMA-free 
growth medium for another 24 h. In co-culture, ketoconazole had a 
much higher toxicity to THP-1 cells, compared to the HepG2 cells 
(Granitzny et al., 2017). In contrast, the differentiation with 100 nM 
PMA for 24 h without a resting phase decreased the toxicity of keto-
conazole (Wewering et al., 2017a). In order to warrant a high ad-
herence of the THP-1 cells and a similar toxicity of drugs to THP-1 cells 
and HepG2 cells, 100 nM PMA was used for differentiation. 
In Fig. 1 the set-up of a co-cultivation can be seen. In order to fur-
ther investigate the differentiation protocol used, the basic property of 
phagocytosis of PMA differentiated THP-1 cells (Kurynina et al., 2018) 
was confirmed (Fig. 1B). The THP-1 cells were capable of active pha-
gocytosis from the beginning of co-cultivation to the end. Therefore, all 
cultures were incubated for 24 h and culture medium with 0.1% DMSO 
was used as control. 
2.3. Cell viability testing 
The MTT Assay was performed according to Mosmann (Mosmann, 
1983). All values were corrected for the solvent control DMSO. 
2.4. RNA isolation 
RNA was isolated using the NucleoSpin® RNA Kit (Machery-Nagel, 
Düren, Germany). 
2.5. Microarray analyses 
All samples (RNA integrity number (RIN) > 8.5) were analysed 
using a Human Clariom™ S Assay (Applied Biosystems, Foster City, CA, 
USA). Microarray data have been deposited in the Gene Expression 
Omnibus (GEO) database, www.ncbi.nlm.nih.gov/geo (accession no. 
GSE140141). To analyse microarray data, the exclusion criterion of 
p ≤ 0.05 was used. Detailed information is provided in the supple-
mentary material. 
2.6. Cytokines 
Cytokines in the supernatant were measured using the Cytokine 
LEGENDplex™ including Anti-Virus Response Panel (IL-8, IL-6, human 
fibroblast growth factor (hFGF)), Cytokine Panel 2 (interleukin 1α (IL- 
1α)) and Growth Factor Panel (TGF-α, GM-CSF, granulocyte colony- 
stimulating factor (G-CSF)) (Biolegend, San Diego, CA, USA). The re-
sults were analysed using LEGENDplex™ 8.0 software (Biolegend, San 
Diego, CA, USA). TGF-β was quantified using the BD™ Cytometric Bead 
Array (CBA) with the Human TGF-β1 Single Plex Flex Set (BD 
Biosciences, Heidelberg, Germany) and analysed with FCAP Array 
v1.0.1 software (BD Biosciences, Heidelberg, Germany). 
2.7. PCR analyses 
Reverse transcription was performed with the High-Capacity cDNA 
Reverse Transcription Kit (Applied Biosystems, Foster City, CA, USA). 
Quantitative PCR (qPCR) was performed with a 7500 Fast Real-Time 
PCR Instrument using Fast SYBR Green Master Mix (Applied 
Biosystems, Foster City, CA, USA). The primer sequences are listed in 
table S2. The ∆∆CT-value was calculated according to Livak and 
Schmittgen (Livak and Schmittgen, 2001) and normalized to the ex-
pression of hypoxanthine-guanine phosphoribosyl transferase (HPRT) 
and to the corresponding control sample. Positive controls were gen-
erated by the treatment with 10 nM 2,3,7,8-tetrachlorodibenzo-p-di-
oxin (TCDD) (LGC Standards, Wesel, Germany) or 1 μM lovastatin be-
fore RNA isolation. 
2.8. Western blots 
Cells were lysed at 4 °C in RIPA buffer (50 mM Tris/HCl (pH 7.4), 
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159 mM NaCl, 1 mM EDTA, 1% Igepal®, 0.25% sodium deoxycholate) 
supplemented with a protease inhibitor cocktail (Merck, Darmstadt, 
Germany). Protein concentrations were determined with the Pierce™ 
BCA Protein Assay Kit (Thermo Scientific, Waltham, MA, USA), and 
equal amounts of protein were applied to SDS-PAGE and transferred 
onto nitrocellulose membranes. After binding of primary antibodies 
(24 h at 4 °C), the secondary antibody (horseradish peroxidase labelled) 
was added, and visualized with Pierce ECL Substrate (Thermo Fisher 
Scientific, Waltham, MA, USA) using a ChemiDoc XRS (Bio-Rad, 
Munich, Germany). 
2.9. CYP1A1 activation 
CYP1A1 activation was measured using the P450-Glo™ CYP1A1 
Assay System (Promega Corporation, Madison, WI, USA). 
2.10. Cholesterol measurements 
The cholesterol concentration was quantified using the Amplex™ 
Red Cholesterol Assay Kit (Thermo Fisher Scientific, Waltham, MA, 
USA). 
2.11. Lipid staining 
The cellular layer was fixed with Roti®-Histofix 4% (Roth, Karls- 
ruhe, Germany) for 10 min, and cells were permeabilized with 0.2% 
TRITON™X-100 for 10 min. Lipids were stained using a freshly prepared 
6 mM Sudan Red 7 B solution in 60% 2-propanol for 10 min. After 
carefully removing excess staining solution, nuclear staining was per-
formed with 1 μg/ml Hoechst3342. Images were repeatedly taken using 
an Olympus BX51 microscope (U Plan FLN 20×/0.50) connected to a 
ColorView III camera (Olympus, Hamburg, Germany). Finally, the 
number of nuclei and the areas of stained droplets were calculated 
using CellProfiler® 3.1.5 software (Carpenter et al., 2006) An example 
of the evaluation and its calculation is given in fig. S1. 
2.12. ATP measurements 
The ATP concentration was determined using a Bioluminescence 
Assay Kit HS II (Roche, Basel, Switzerland). 
2.13. Collagen staining 
The Sirius Red/Fast green collagen staining kit (AMS Biotechnology, 
Abingdon, UK) was used. 
2.14. Statistics 
Detailed information on the exploratory grouping analysis is pro-
vided in the supplementary section. All data shown contain at least 
three independent biological replicates. Means, standard deviations and 
ANOVA p-values followed by Bonferroni correction were calculated 
Fig. 1. Set-up of the co-cultivation and phagocytic capacity of THP-1 cells. THP-1 cells were differentiated using 100 nM phorbol-12 myristat-13 acetat (PMA) for 
24 h and the co-cultivation with HepG2 starts without a resting phase. (A) Shown are set-up und photomicrographic images at the beginning (t = 0) and the end 
(t = 24 h) of the co-cultivation. (B) Phagocytosis is a characteristic of PMA differentiated THP-1 cells. The internalization of latex beads (2 μm, 5 μl/ml culture 
medium) after 2 h incubation is temperature dependent (4 °C or 37 °C). The white arrow indicates exemplarily the latex beads. The scale bar denotes 20 μm. 
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with GraphPad Prism 6 (Statcon, Witzenhausen, Germany). Analysed 
gene lists were selected due to the pathway relevance and the sig-
nificance (p  <  0.05) using Ingenuity® Pathway Analysis (Qiagen, 
Aarhus, Denmark). The Z-score and the hierarchical clustering were 
calculated with Perseus Software (Tyanova et al., 2016). Three-di-
mensional figures were generated using Plotly (https://plot.ly) (Plotly 
Technologies Inc, 2015). 
3. Results 
3.1. Toxicity of selected substances on 100 nM PMA diffentiated THP-1 
cells 
The toxicity of drugs, used in co-cultivation experiments should 
have similar half effective concentrations for all cell lines. PMA dif-
ferentiated THP-1 cells are very sensitive against drugs (Granitzny 
et al., 2017). Therefore, in a first step, we tested the effect of three 
different drugs on the cell viability of PMA differentiated THP-1 cells, 
after single and co-culture. The selected PMA concentration was 
100 nM (c.f. 2.2). 
The loss of cell viability induced by primaquine, flutamide and 
amiodarone (Fig. 2) was almost lower or equal (Fig. 2) for co-cultivated 
THP 1 cells compare to the corresponding single cultivation. Therefore, 
THP-1 differentiation with 100 nM PMA for 24 h without a resting 
phase was chosen for all experiments, in order to obtain high adherence 
and low loss of viability of the THP-1 cells. 
3.2. Exploratory grouping analysis highlights differences between single- 
and co-cultivated HepG2 cells 
Outlier and batch effects can occur if there are any differences in 
batch-to-batch cultivation conditions or in the handling and prepara-
tion of samples. These outliers can be identified, for example, by ex-
ploratory grouping analysis (Bro and Smilde, 2014). We compared the 
cultivation conditions (single- and co-cultivation) of HepG2 cells and 
PMA-differentiated THP-1 cells (Fig. 3). The distances of the individual 
samples in terms of expression profiles indicate that the variation in the 
data is mainly affected by culture conditions (single- vs. co-cultivation) 
and the kind of cell type (HepG2 or THP-1), but not by batch-to-batch 
variations between individual samples. Therefore, the presence of 
outliers and a batch-to-batch variation was excluded and all samples 
were included in the subsequent analyses. 
3.3. Genes associated with liver inflammation are upregulated 
The analysis of the transcriptomes identified differentially expressed 
cytokines and cytokine receptors. A total of 73.9% of the significantly 
upregulated genes (p  <  0.05) were associated with liver inflammation 
(Fig. 4A). Based on these microarray data, we quantified a selection of 
secreted cytokines in the cell culture supernatants (Fig. 4B). To identify 
the cell type responsible for the secretion (HepG2 or THP-1), we also 
quantified cytokine concentrations in pure THP-1 and HepG2 (single 
cell) cultures. Among the set of cytokines investigated, hFGF, TGF-α, 
and G-CSF were only detectable under co-cultivation conditions 
(Fig. 4B), whereas HepG2 cells alone also secreted GM-CSF and IL-6. 
However, the levels of these two biomarkers were still further and 
significantly (p  <  0.01) upregulated under the condition of co-culti-
vation with THP-1 cells. Conversely, PMA-differentiated THP-1 cells 
alone secreted IL-8 to a much higher extent than did HepG2 cells alone. 
IL-8 levels under co-cultivation conditions were again in the same range 
as observed for THP-1 cells in the absence of HepG2 cells. In contrast, 
TGF-β concentrations in the supernatant were 2-fold higher (non-sig-
nificantly) under co-cultivation than in individual cell cultures but re-
presented approximately the sum of levels that were measured in the 
latter. Interestingly, the cytokine IL-1α was only detectable when THP- 
1 cells were cultured alone but absent in HepG2 cell cultures or co- 
cultures of THP-1 and HepG2 cells. 
In conclusion, the secretion differed between individually cultivated 
cells and the co-cultivation of HepG2 with differentiated THP-1 cells 
(Fig. 4). 
3.4. Pro-inflammatory conditions in co-culture activate the AHR signalling 
pathway 
Next, we were interested, whether xenobiotic metabolism might be 
affected under co-culture conditions. Therefore, genes representing 
phase I and phase II xenobiotic metabolism whose expression levels 
were found to be significantly elevated were selected from the micro-
array data (Fig. 5A). Using Ingenuity® Pathway Analysis (IPA®) soft-
ware, we concluded that most (70.0%) of these genes were 
Fig. 2. Dose dependent loss of cell viability on co- and single-cultivated THP-1 cells. THP-1 cells were exposed to increasing concentration of primaquine, flutamide, 
or amiodarone for 24 h in co- (CC) or single-(SC) cultivation condition. Viability was determined using a MTT assay. All values were corrected to % of the 
corresponding DMSO solvent controls. n = 3, **p  <  0.01. 
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downregulated (Fig. 5A). In addition, the IPA® analysis indicated the 
activation of the AHR in co-culture. Immunoblot assays confirmed an 
increase in the amount of AHR protein in HepG2 cells after co-culti-
vation and a comparable amount of aryl hydrocarbon receptor nuclear 
translocator (ARNT) (Fig. 5B). As a result, known AHR target genes 
were transcriptionally upregulated in co-cultivated HepG2 cells com-
pared to single-cultivated HepG2 cells (Fig. 5C): 74-fold for CYP1A1, 
48-fold for CYP1A2 and 4-fold for CYP1B1. 
Next, we studied, whether a classical inductor of AHR, 2,3,7,8-tet-
rachlorodibenzo-p-dioxin (TCDD), is able to further induce the 
expression of AHR target genes in co-culture. Therefore, we treated 
single- and co-cultivated cells with the AHR activator TCDD. Compared 
to treated single-cultivated HepG2 cells, the co-cultivated HepG2 cells 
showed clearly upregulated CYP1A2 and CYP1B1 gene expression, only 
(Fig. 5D). The additional induction of CYP1A1 by TCDD was only 
minor. Finally, we were interested, whether the increased gene and 
protein expression resulted in increased enzyme activity of the target 
gene. The enzyme activity of CYP1A1 was significantly higher 
(p  <  0.01) in co-cultivated HepG2 cells than in individually cultivated 
HepG2 cells (Fig. 5E), indicating that the AHR receptor pathway was 
Fig. 3. Exploratory grouping analysis shows that the cultiva-
tion conditions affect gene expression profiles to a larger ex-
tent than the factor of sample-to-sample variability within the 
same group. HepG2 cells were cultivated with PMA-differ-
entiated THP-1 cells in co-culture (●, HepG2 CC, n = 5) and 
compared to single cultivated HepG2 (○, HepG2 SC, n = 5) or 
PMA-differentiated THP-1 (single cell) cultures (□, THP-1, 
n = 3) for 24 h. 
Fig. 4. Inflammation is induced in the co-culture of HepG2 and differentiated THP-1 cells. (A) Heat map of HepG2 cells in single culture (SC) or co-culture (CC) with 
PMA-differentiated THP-1 cells after 24 h (n = 5). Gene symbols and the Z-score of significantly (exclusion p  >  0.05) up- or downregulated genes based on the IPA 
gene list are shown. An enlarged heat map is shown in the supplementary material (S2). (B) Secretion of TNF-α, IL-8, TGF-α, IL-6, GM-CSF, G-CSF, TGF-β and hFGF in 
the supernatant of individually cultured and co-cultivated cells after 24 h (n = 6). The means and standard deviations (SD) are shown with the upper (UDL) (−–) and 
the lower detection limits (LDL) of the assay (∙∙∙). **p  <  0.01. 
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not only activated but also resulted in higher amounts of functional 
enzyme. 
This result implies that compared to the individual cultivation of 
HepG2 cells, the co-cultivation of HepG2 cells with differentiated THP- 
1 cells results in the activation of AHR target genes and an increased 
CYP1A1 enzyme activity. 
3.5. Cholesterol biosynthesis is enhanced in co-culture 
The liver is the main organ of cholesterol synthesis. The microarray 
data revealed that all genes in the cholesterol biosynthesis pathway 
were significantly (p  <  0.05) downregulated under co-cultivation 
compared to individual cultivation (Fig. 6A). In contrast, the cellular 
cholesterol concentration was significantly increased in co-cultivated 
HepG2 cells after 24 h relative to the individually cultivated cells 
(Fig. 6B). Thus, we studied these contradictory results in more detail. 
HepG2 cells were treated with the HMG-CoA reductase inhibitor lo-
vastatin, and the expression of a master regulator of cholesterol 
synthesis, sterol regulatory element binding transcription factor 1 
(SREBF1) (Shimano et al., 1996), was determined (Fig. 6C). As ex-
pected, lovastatin treatment induced the significant upregulation (2- 
fold) of the transcription factor SREBF1 in single culture. In co-culture, 
however, a 1.5-fold downregulation was detected (Fig. 6C). This 
treatment-dependent regulation indicated the presence of a negative 
feedback mechanism in co-culture. For clarification, we determined the 
cellular cholesterol concentration in single- and co-cultivated HepG2 
cells after lovastatin treatment. In single-cultivated cells, the amount of 
cholesterol decreased relative to the level in co-cultivated cells 
(Fig. 6B). To further evaluate the effect of lovastatin, we compared 
individually cultivated and co-cultivated cells at different time points. 
In individually cultivated HepG2 cells, the effect of lovastatin occurred 
after 48 h (Fig. 6D). However, in co-cultivated cells, a significant 
(p  <  0.05) reduction in the cellular cholesterol concentration occurred 
after 24 h and remained constant for 48 h (Fig. 6D), indicating that 
lovastatin affected the lipid metabolism in co-cultivated cells responded 
faster than in individually cultivated cells. 
In summary, we have shown that cholesterol biosynthesis is in-
creased in co-cultivated HepG2 cells, despite reduced SREBF1 expres-
sion. The cholesterol-lowering effect of lovastatin occurred earlier in 
co-culture than in individual culture. 
3.6. Total lipid synthesis is decreased in co-culture 
Next, we were interested, whether the total lipid amount and the 
related metabolism were affected during co-cultivation. Transcriptional 
analysis showed that 65% of the significantly (p  <  0.05) regulated 
Fig. 5. Effects of co-cultivation on xenobiotic metabolism. (A) HepG2 cells were cultivated in single culture (SC) or co-culture (CC) for 24 h (n = 5). The gene 
symbols and the Z-score of significantly and differentially expressed genes are shown. (B) Co-cultivation increased the amounts of AHR and ARNT. One representative 
blot of three biological replicates is shown. (C) Co-culture of HepG2 cells resulted in the increased expression of CYP1A1 and CYP1A2 gens, compared to single- 
cultivated cells. (D) Addition of 10 nM TCDD in CC systems resulted in no further induction of cytochrome P450 1A1 (CYP1A1), but an additional induction of 
cytochrome P450 1A2 (CYP1A2), and cytochrome P450 1B1 (CYP1B1) expression (n = 3). (E) Compared to individually cultivated cells, HepG2 cells in co-culture 
showed increased cytochrome P450 1A1 (CYP1A1) enzyme activity (n = 6). **p  <  0.01. 
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genes related to lipid metabolism were upregulated in co-culture 
(Fig. 7A). However, these significantly upregulated genes could not be 
assigned to a distinct lipid metabolic pathway. Therefore, we quantified 
the amount of lipid droplets in HepG2 cells upon individual cultivation 
and co-cultivation. In general, the total area of lipid droplets in HepG2 
cells was significantly (p  <  0.01) reduced in co-culture by 76% 
(Fig. 7B). To further elucidate this result, we studied the expression and 
concentration of fatty acid synthase (FAS), a key enzyme in lipid 
synthesis. The gene array data (Fig. 7A) and qPCR showed that the 
expression of FASN in HepG2 cells was significantly downregulated by 
0.6-fold and that the protein concentration was reduced by 0.7-fold 
under co-culture conditions, supporting the reduction in the amount of 
lipid droplets (Fig. 7C+D). 
Accordingly, total lipid synthesis seems to be lowered in co-culti-
vated HepG2 cells. 
3.7. Co-culture activates key events of the AOP fibrosis 
The global transcriptome analysis of the co-culture indicated an 
increased expression of genes related to liver fibrosis. To validate this 
prediction, we studied key events (KE) of the adverse outcome pathway 
number 38 (Landesmann, 2016), visualized the presence of extra-
cellular collagen and determined the upregulation of fibrosis-related 
genes (Fig. 8). The ‘KE 1’ requires hepatocyte injury. Hepatocyte injury 
is often related to the amount of intracellular ATP, which was sig-
nificantly (p  <  0.01) reduced in co-cultivated HepG2 cells (Fig. 8B). 
‘KE 2’ is the activation of Kupffer cells (KC). The transcriptome analysis 
of all associated genes (e.g., cytokines and corresponding receptors) 
showed KC activation. In brief, 86% of all significantly (p  <  0.05) 
regulated genes examined for KE 2 were upregulated (Fig. 8C). Re-
garding ‘KE 3’, enhanced TGFB1 expression was detected (up to 1.7- 
fold) in co-cultivated HepG2 cells compared to individually cultivated 
cells (Fig. 8D). The activation of these key events should result in an 
accumulation of collagen in the co-culture system. Staining and pho-
tometric quantification shows that a rather small but significant 
(p  <  0.05) accumulation (1.14-fold) of collagen occurred in co-culti-
vated HepG2 cells (Fig. 8E). In order to validate these unexpected 
finding further, the presence of extracellular collagen was analysed 
using Sirius Red (Fig. 8F). The images clearly proved, that staining 
occurred in cells and not, as expected for the extracellular matrix, 
outside of the cells. Finally, the expression of genes related to fibrosis 
was studied. In the co-culture the expression of pro-fibrotic genes for 
smooth muscle α actin (ACTA2) and SMAD family member 7 (SMAD7) 
were down-regulated and only the expression of SMAD family member 
3 (SMAD3) was upregulated, relative to the single cultured HepG2 cells 
(Fig. 8G). 
Fig. 6. Effects of co-culture on cholesterol biosynthesis. (A) Heat map of HepG2 cells in single culture (SC) or HepG2 cells co-cultured (CC) with PMA-differentiated 
THP-1 cells after 24 h (n = 5). The gene symbols and the Z-score of significantly (exclusion p  >  0.05) expressed genes are shown. (B) Co-cultivation increased the 
relative cholesterol concentration in co-cultivated HepG2 cells. This increase was suppressed by 1 μM lovastatin. (C) Lovastatin (1 μM) increased the expression of 
sterol regulatory element binding transcription factor 1 (SREBF1) in individually cultivated HepG2 cells. During co-cultivation, the expression of SREBF1 was 
decreased in HepG2 cells (n = 3). (D) Cholesterol concentration in co-cultivated lovastatin-treated HepG2 cells decreased after 24 h and remained constant for 48 h. 
Cholesterol concentration in individually cultivated HepG2 cells decreased after 48 h relative to the corresponding DMSO control. Measurement data (•,▪), 
mean  ±  SD and respective control (∙∙∙) are shown. *p  <  0.05 and **p  <  0.01. 
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In summary, while several of the KEs of the AOP fibrosis are met, 
the co-culture does not represent a fibrotic state and is in its present 
form not useful for studying fibrosis. 
4. Discussion 
In this study, we characterized changes at the cellular level that 
were induced by the co-cultivation of HepG2 and PMA-differentiated 
THP-1 cells. The main focus was on the hepatic cell line. Transcriptome 
analyses of co-cultivated and individually cultivated HepG2 cells were 
taken as the basis for all further investigations. The previously reported 
pro-inflammatory properties of this co-culture (Wewering et al., 2017a;  
Granitzny et al., 2017; Wewering et al., 2017b) were studied in close 
detail in order to characterize the system further. Except for IL-1α, the 
concentrations of all detected cytokines were found increased in the 
supernatant of co-cultivated cells (Fig. 4B). 
Next, we compared the cytokine concentration measured under co- 
cultivation conditions with reported serum concentrations of healthy 
humans. The IL-6 concentration in our in vitro model was in a similar 
range as found in healthy human serum (Table 1), and GM-CSF is the 
only cytokine that showed a lower concentration than the reported 
values (Table 1). All other detected cytokines (IL-8, TGF-α, G-CSF, TGF- 
β, hFGF) had higher concentrations in the supernatant of the co-culture 
than in healthy human serum (Table 1). Even though that the absolute 
numbers of the in vitro concentrations are not directly comparable with 
the in vivo data, the concentrations are in the same range. Surprisingly, 
IL-1α was only detected in the supernatant of THP-1 cells under single 
culture conditions (Fig. 4B). Under co-cultivation conditions, no se-
cretion was detectable, hence indicating that indirect cell-cell interac-
tions (HepG2-THP-1) occurred. Therefore, co-cultivation is associated 
with the release of the inflammatory cytokines IL-8, TGF-α and G-CSF 
in the supernatant, most likely due to complex cell-cell interactions. 
Xenobiotic metabolism is also affected in a pro-inflammatory en-
vironment. An increase in the IL-6 serum levels of patients undergoing 
allogeneic bone marrow transplantation was associated with a decrease 
in cyclosporine metabolism (Chen et al., 1994). The liver is important 
for phase I and phase II metabolism of xenobiotic substances 
(Anzenbacher and Zanger, 2012), and it has been shown that cytokines 
Fig. 7. Lipid metabolism. (A) Heat map of differentially expressed genes in HepG2 cells in single culture (SC) and co-culture (CC) with PMA-differentiated THP-1 
cells. The gene symbols and the Z-score (exclusion p  >  0.05) after 24 h are shown (n = 5). (B) Effect of SC and CC on the intracellular lipid droplet area (normalized 
to cell number) of HepG2 cells after 24 h (n = 3). Each dot (●) represents a microscopic image. (C) HepG2 cells cultivated for 24 h in CC, showed reduced expression 
of fatty acid synthase (FASN) normalized to SC (∙∙∙) and HPRT (n = 10). The amount of fatty acid synthase (FAS) protein in CC was slightly reduced compared to in the 
SC (∙∙∙) of HepG2 (●) or THP-1 (▪) cells (n = 3). (D) Amount of FAS protein under SC and CC conditions. **p  <  0.01, ***p  <  0.005. 
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can affect biotransformation (Prescott et al., 1975). Xenobiotic meta-
bolism (membrane transport, phase I and phase II) is reduced by 10 ng/ 
ml IL-6 in primary human hepatocytes and HepaRG cells (Klein et al., 
2015). In addition, the phase I enzyme CYP1A1 is repressed by IL-6 and 
TNF-α in primary human hepatocytes (Muntane-Relat et al., 1995). 
Previously, we have shown that the secretion of TNF-α increases under 
co-cultivation conditions up to 63.5 pg/ml (Padberg et al., 2019), and 
here we report that the IL-6 concentration was 3.9 pg/ml (Table 1). In 
contrast to the reported data (Muntane-Relat et al., 1995), CYP1A1 
enzyme activity also increased (Fig. 5E), indicating that the interaction 
of cytokines and xenobiotic metabolism might be more complex and 
different in the HepG2 and THP-1 co-culture system than in in-
dividually cultivated primary hepatocytes. The upregulation of CYP1A1 
in the co-cultivated HepG2 cells could also be induced by other non- 
investigated pathways/receptors, such as the constitutive androstane 
receptor (CAR) and the liver X receptor α signalling (LXRα) pathways 
(Santes-Palacios et al., 2016). Indeed, the AHR pathway was activated 
in co-cultivated HepG2 cells. An assessment based on the higher con-
centration of AHR (Fig. 5B) and upregulated expression of the target 
genes CYP1A1, CPY1A2 and CYP1B1 (Fig. 5C). Interestingly, Nguyen 
and co-workers showed that humans exposed to dioxin (a potent acti-
vator of the AHR pathway) showed significantly increased gene ex-
pression of TNF and IL-6 in whole blood cells (Nguyen et al., 2017). In 
addition to ligand-dependent activation, AHR overexpression can also 
result from the expression of IL-6 (Chen et al., 2011). Therefore, we 
concluded that the expression and activation of AHR in the co-culture 
Fig. 8. Application of key events of the adverse outcome pathway (AOP) of ‘fibrosis’ (A) AOP analysis according to Horvat and co-workers (Horvat et al., 2017), 
including the gene symbol of transforming growth factor β 1 (TGFB1) and the extracellular matrix (ECM). (B) ATP concentration per g total protein of HepG2 cells 
cultivated for 24 h under single culture (SC) or co-culture conditions (CC) with PMA-differentiated THP-1 cells. Individual measurement data (○, ●), mean  ±  SD are 
given (n = 3). (C) HepG2 cells were cultivated under SC or CC for 24 h (n = 5). The gene symbols and the Z-score of significantly (exclusion p  >  0.05) and 
differentially expressed relevant genes for Kupffer cell activation are shown (Horvat et al., 2017). An enlarged heat map is shown in supplementary fig. S3. (D) 
Expression of TGFB1 normalized to SC (∙∙∙) HepG2 cells or PMA-differentiated THP-1 cells (▪) and HPRT are shown (n = 11). (E) The concentration of collagen 
significantly increased under the CC with HepG2 cells and PMA-differentiated THP-1 within 24 h. Data were normalized to the total amount of non-collagenous 
protein (n = 3). (F) Representative microscopic image of HepG2 cells after cultivation under SC or CC for 24 h. The collagen staining (Sirius Red) was exclusively 
detectable in the intracellular compartments. (G) Fold change (CC relative to SC, n = 5) of fibrosis associated gene expression assessed from the transcriptomic 
analysis, including the respective p-value. The gene for smooth muscle α actin (ACTA2) and SMAD family member 7 (SMAD7) were downregulated in CC compared 
to SC, while SMAD family member 3 (SMAD3) was upregulated. *p  <  0.05, **p  <  0.01, and ***p  <  0.005. (For interpretation of the references to colour in this 
figure legend, the reader is referred to the web version of this article.) 
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resulted from increased cytokine signalling, which finally results in an 
increased enzyme activity (Fig. 5E). 
In addition to the biotransformation of xenobiotics, the liver is 
crucial for lipid metabolism, including cholesterol biosynthesis (Repa 
and Mangelsdorf, 2000). The biosynthesis of cholesterol increases in the 
co-culture system (Fig. 6), while the amount of total lipids, determined 
as lipid droplets, is reduced (Fig. 7B). 
An increase in the sensitivity of co-cultured HepG2 cells towards 
lovastatin, a classical sterol biosynthesis inhibitor, occurred under co- 
cultivation (Fig. 6D). Lovastatin (HMG-CoA reductase inhibitor) re-
duced the cholesterol concentration in the co-culture after 24 h. In 
contrast, the reduction occurred in single-cultivated HepG2 only after 
48 h. This result demonstrates that the co-culture system has an im-
proved sensitivity towards a classical sterol biosynthesis inhibitor. 
Previously, enhanced sensitivity to the DILI-inducing substance keto-
conazole was demonstrated due to increases in oxidative stress-related 
proteins and pro-inflammatory cytokine secretion (Wewering et al., 
2017a). This finding was supported by a mechanistic approach, testing 
a larger set of drugs (Granitzny et al., 2017). Therefore, it is concluded 
that the co-culture exhibits not only a higher sensitivity to DILI-indu-
cing substances but might also respond more rapidly to drug exposure. 
This has to be studied in more detail in future. Whether this enhanced 
sensitivity is based on the reduced lipid droplets in the co-cultivated 
HepG2 (Fig. 7B) remains also to be proven. It is known that lipid dro-
plets maintain organelle homeostasis and prevent reactive oxygen 
species (ROS), lipid overload, hypoxia and apoptotic cell death (Baenke 
et al., 2013). 
Surprisingly, the increased cholesterol biosynthesis (Fig. 6) does not 
lead to an increase in total lipids (Fig. 7B), but rather to a decrease in 
the number of lipid droplets. Since acetyl-CoA is the common precursor 
of cholesterol and fatty acids, it can be concluded that acetyl-CoA is not 
limited and that the regulation of the two pathways must occur at later 
stages. We identified a decrease in the lipid droplet area per cell 
(Fig. 7B) and validated the hypothesis that de novo fatty acid (FA) 
synthesis was reduced in co-culture, since the gene expression of FAS 
and the amount of FAS protein was decreased in the co-culture com-
pared to the individual cultures (Fig. 7C+D). The reduction of FAS and 
the lipids indicates, that the β-oxidation of FA is increased in co-culti-
vation compared to HepG2 cells alone, thereby providing ATP. The 
decreased intracellular ATP amount in co-cultivated HepG2 cells sup-
ports this (Fig. 8B). An increased CYP expression (Fig. 5C) and protein 
biosynthesis (Fig. 5E) supports the need for energy further, because 
protein biosynthesis is one of the most energy consuming cellular 
processes (Lindqvist et al., 2018). Also the enhanced cholesterol bio-
synthesis in co-cultivation (Fig. 6) is an ATP demanding anabolic 
pathway (Korman et al., 2014). Taken together the co-cultivated HepG2 
cells have an higher ATP demand compared to the HepG2 cells alone 
and this is most likely covered by the oxidation of FA. 
The aforementioned changes in lipid metabolism can be closely 
linked to the inflammatory environment during co-cultivation. The 
hormone leptin promotes FA oxidation, resulting in a reduction of he-
patic triglycerides and cytokine secretion (GM-CSF, IL-1α, IL-1β, IL-6, 
IL-10 and IL-18) in murine KC in vitro (Metlakunta et al., 2017). 
However, the authors showed that typical leptin-induced FA oxidation 
was not a consequence of the cytokine release (Metlakunta et al., 2017). 
This result provides evidence that the interplay of the cytokines with 
each other and with cells and tissues is complex. IL-6 is a pleiotropic 
cytokine and has multiple effects on hepatic lipid metabolism (Hassan 
et al., 2014). In general, lipid metabolism is disturbed during in-
flammatory processes (Tall and Yvan-Charvet, 2015). 
The inflammatory pattern of the co-culture does not indicate a pa-
thophysiological pattern like non-alcoholic fatty liver disease (NAFLD) 
or steatohepatitis, even though the typical pro-inflammatory cytokines 
(e.g., IL-6, IL-8 and TNF-α) are increased (Braunersreuther et al., 2012;  
Niederreiter and Tilg, 2018). Since the lipid droplet area in the pre-
sented co-culture was reduced (Fig. 7B), the system did not represent a 
true model of fatty liver disease. 
A pro-inflammatory co-culture system might also enable the in-
vestigation of liver fibrosis in vitro. Liver fibrosis is associated with 
abundant extracellular matrix (ECM) proteins, like collagen. Hepatic 
stellate cells are the main mediators of ECM production (Bataller and 
Brenner, 2005). Recently, Prestigiacomo and co-workers 
(Prestigiacomo et al., 2017) developed a co-culture system, composed 
of three cell lines: HepaRG, differentiated THP-1 and hTERT-HSC for 
studying fibrosis. ECM production and fibrosis become clinically re-
levant when dysregulated, eventually leading to chronic liver diseases 
(Pellicoro et al., 2014). This liver injury can be induced in vitro using 
the indirect co-cultivation of rat hepatic stellate cells and rat KCs 
(Nieto, 2006). In the presented co-cultivation system, the main key 
events of the AOP for fibrosis (Horvat et al., 2017) were observable 
(Fig. 8). Due to the absence of stellate cells, however, we were unable to 
prove key event 4, that is, the activation of the latter cell type. Stellate 
cells are an essential contributor to hepatic fibrosis (Horvat et al., 
2017). A small but significant collagen accumulation, could be con-
firmed (Fig. 8E) in HepG2 cells. The synthesis of collagen 1 by HepG2 
cells has been reported (Zhang et al., 2020), and that collagen pro-
duction can be induced by 10 μM all-trans retinoic acid (Wang et al., 
2013). This finding shows that stellate cell-independent collagen ac-
cumulation can occur in vitro. While several KE of the AOP fibrosis were 
detected in our co-culture system, it does not represent a fibrotic state, 
because there was no extracellular accumulation of collagen (Fig. 8F). 
In addition, ACTA2 and SMAD7 (Rockey et al., 2019), important during 
the development of fibrosis were downregulated (Fig. 8G) and only 
SMAD3 was upregulated, relative to the single culture. Therefore, this 
example demonstrates, that AOPs should be used with care. The pre-
sence of KE are important parameters in an AOP, but in the case of 
complex pathological processes like fibrosis the presence of KE might be 
misleading. Especially, if in vitro systems do not consist of the cell types 
relevant for the pathological process. Stellate cells in the case of fi-
brosis. This is clearly demonstrated by an in vitro co-culture system of 
HepRG, THP-1 and a stellate cell line, that is able to mimic the fibrotic 
pathology (Prestigiacomo et al., 2017). 
5. Conclusion 
Biochemical changes that were induced by the co-cultivation of 
HepG2 and PMA-differentiated THP-1 cells were characterized. In 
general, indirect co-cultivation was associated with an inflammatory 
cytokine composition in the supernatant. Enzymes involved in xeno-
biotic metabolism (CYP1A1, CYP1A2 and CYP1B1) increased, as de-
termined by mRNA expression. Besides differential gene expression the 
Table 1 
Comparison of cytokine concentration in the supernatant of co-cultivated 
HepG2 cells with THP-1 cells and healthy human serum. The following cyto-
kines were quantified: interleukin 8 (IL-8), transforming growth factor α (TGF- 
α), interleukin 6 (IL-6), granulocyte macrophage colony-stimulating factor 
(GM-CSF), granulocyte colony stimulating factor (G-CSF), transforming growth 
factor β (TGF-β), human fibroblast growth factor (hFGF) and interleukin 1 α 
(IL-1α). The mean concentration ( ± SD) in the co-culture supernatant and the 
mean concentration and concentration range in human serum are shown.      




(range) in healthy 
human serum [pg/ml] 
Reference for serum 
concentrations  
IL-8  > 12,603.06 (−) 29.3 (24.4–35.9) (Kleiner et al., 2013) 
TGF-α 56.87 (27.47) 3.2 (0.93–26.8) (Kim et al., 2011) 
IL-6 3.95 (0.58) 2.91 (0.16–37.7) (Kim et al., 2011) 
GM-CSF 10.22 (3.33) 38.3 (26.3–63.8) (Kleiner et al., 2013) 
G-CSF 1162.29 (485.3) 45.5 (34–53.6) (Kleiner et al., 2013) 
TGF-β 96.37 (90.08) 49.1 (not given) (Wu et al., 2002) 
hFGF 138.48 (110.09) 41.7 (33.2–49.5) (Kleiner et al., 2013) 
IL-1α  < 1.89  < 1.4 (Kleiner et al., 2013) 
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enzymatic activity also increased. These observations were due to ac-
tivation of the AHR signalling pathway. In addition, the lipid metabo-
lism was disturbed, indicated by an increased cholesterol biosynthesis, 
a shortened reaction time upon lovastatin treatment, and a reduced de 
novo fatty acid synthesis. 
In summary, the co-culture of HepG2 and PMA-differentiated THP-1 
is a simple in vitro method with increased release of inflammatory cy-
tokines (IL-8, TGF-β, IL-6, GM-CSF, G-CSF, TGF-β and hFGF) and an 
activated AHR pathway with differential expression of genes related to 
biotransformation and an increased CYP1A1 enzymatic activity. 
Finally, we consider that this co-cultivation is a method for a fast and 
uncomplicated screening of substances that affect the release of pro- 
inflammatory cytokines or AHR signalling and related enzyme activ-
ities. 
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